GSP Crop Science IPO : Details, Price Band, Lot Size and Company Overview

GSP Crop Science Business Overview:

GSP Crop Science Limited is an agrochemical manufacturer engaged in the development, production, and distribution of crop protection products. Incorporated in 1985, the company focuses on manufacturing insecticides, herbicides, fungicides, and plant growth regulators that help farmers improve crop productivity and manage pests, weeds, and plant diseases.

The company operates across the agrochemical value chain through the production of Technicals (concentrated active ingredients) and Formulations (finished crop protection products containing active ingredients and additives). Its portfolio includes a wide range of in-house manufactured agrochemical solutions tailored for different crop protection requirements.

GSP Crop Science has established a diversified geographic presence. In India, the company serves customers across 20 states. Internationally, it exports products to 37 countries, including the United States, Brazil, Uruguay, Vietnam, Singapore, the UAE, and Australia, with key markets spanning Latin America, North America, and Asia-Pacific.

Innovation remains a key focus area for the company, it has received 524 product registrations across formulations and technical. Its research capabilities are supported by R&D facilities in Kathwada and Odhav, which focus on testing, commercialization, and developing complex agrochemical chemistries. The company has been granted 102 patents, with 108 additional patent applications currently under process.

IPO Synopsis:

Objective of the Issue:

• Repayment of outstanding borrowings availed by the Company - ₹ 170 crores.
• General Corporate Purposes

Strengths:

• Diversified Customer Base with Global Presence:

The company benefits from a well-diversified client base across both B2B and B2C segments. In FY25, the Top 10 customers contributed only about 20% of total revenue, indicating limited client concentration risk. Additionally, around 11% of revenue comes from international markets, highlighting the company’s growing global presence and potential for export led growth.

• Diversified Product Portfolio:

The company offers a broad portfolio of agrochemical products including insecticides, herbicides, fungicides and plant growth regulators. In FY25, insecticides contributed 63% of revenue, followed by herbicides at 17% and fungicides at 13%. While insecticides remain dominant, there has been a downward trend in the contribution of insecticides to the revenue over the past three fiscal years. The company is gradually diversifying its product mix to reduce dependence on a single segment.

• Strong R&D and Manufacturing Capabilities:

The company has developed strong research and manufacturing capabilities supported by R&D centres in Kathwada and Odhav. It has secured 524 product registrations across formulations and technicals, along with 102 granted patents and 108 patent applications under process. Manufacturing capacity includes 15,120 MTPA for technicals, 43,672 MTPA for formulations, and 5,400 MTPA for intermediates across five facilities.

Risks:

• Dependence on Raw Material Imports from China:

The company remains significantly dependent on China for sourcing raw materials. Imports from China accounted for 42.08% in H1 FY26 & 37.99% in FY25 of total purchases. An upward trend of purchasing raw materials is seen from the previous fiscal years. Any disruption due to geopolitical tensions, trade restrictions, tariffs, or supply chain constraints could increase input costs and pressure operating margins.

• Regulatory and Approval Risks:

The company operates in a highly regulated agrochemical industry where product registrations and approvals from the Central Insecticides Board and Registration Committee (CIBRC) are mandatory. Any delay or failure in obtaining or renewing these approvals could impact production and sales. Although the company has maintained a strong approval track record, with 18 out of 21 applications approved in FY25, regulatory uncertainty remains a key operational risk.

• High Reliance on Generic Products:

A large share of the company’s revenue is derived from generic agrochemical products, which face intense competition and limited pricing power. Generic products contributed 82.90% in H1 FY26, 82.58% in FY25, 86.13% in FY24, and 94.17% in FY23 of product sales. Although there has been a decreasing trend in contribution to revenue from sale of generic products but the levels still remain high. Increased competition or pricing pressure in the generics market could adversely impact revenues and profitability.

Financial Snapshot (Rs. In Crores):